(Case T-380/18)

Language of the case: English

Parties

Applicant: Intas Pharmaceuticals Ltd (Ahmedabad, India) (represented by: M. Edenborough, QC)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Laboratorios Indas, SA (Pozuelo de Alarcón, Spain)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union word mark INTAS — Application for registration No 14 153 811

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 16 April 2018 in Case R 815/2017-4

Form of order sought

The applicant claims that the Court should:

—annul the contested decision;

—in the alternative, alter the contested decision to the state that the opposition shall be remitted to the Opposition Division for it to reconsider the opposition;

—order EUIPO to pay the applicant’s costs of and occasioned by this application and the costs before the Board;

—in the alternative, if the other party before the Board intervenes, then order EUIPO and the intervener jointly and severally to pay the applicant’s costs of and occasioned by this application and the costs before the Board.

Plea in law

—Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.